The main objective of the Young Scientist Group within the Society For Biomaterials (SFB) is to facilitate and promote the entry, development, and full participation of young scientists within SFB and the broader biomaterials community. Undergraduate students, graduate students, postdoctoral fellows, young industrial professionals, young faculty, and other young scientists are included in SFB’s Young Scientist Group.
At the upcoming SFB Annual Meeting, in Seattle (April 3-6, 2019), please check out our events below.
How to Join Us:
Please join our email list here to receive updates on our programming and updates to our events during the Annual Meeting: https://form.jotform.com/82834068065158
Julianne Holloway, Ph.D.
Julianne Holloway received her Ph.D. in Chemical Engineering at Drexel University in 2012 and completed her postdoctoral training at the University of Pennsylvania within the Bioengineering Department. Through her research on engineering hydrogels for synergistic biomolecule delivery, she was awarded the National Institute of Health Ruth L. Kirschstein National Research Service Award Postdoctoral (NIH NRSA F32) Fellowship. Her research interests are in the field of tissue engineering, with a focus on designing materials to mimic the native biochemical and biophysical cues of musculoskeletal tissues and developing a better understanding of the role dynamic biomechanics plays on cellular behavior.
Brian Aguado, Ph.D.
Position: Vice Chair (2019), Chair (2020/2021)
Brian Aguado is currently an NIH and Burroughs Wellcome Fund Postdoctoral Fellow at the University of Colorado Boulder. He received his BS in Biomechanical Engineering from Stanford University and his MS and PhD in Biomedical Engineering from Northwestern University. His research is focused on developing precision biomaterials for personalized medicine and seeks to develop personalized models of fibrosis and cancer metastasis.
Kelly Chen-Leung, Ph.D.
Industry Chair (2019)
Kelly Leung received her Ph.D. in Bioengineering from the University of Utah. She then received her postdoctoral training from the US Army Institute of Surgical Research and Wake Forest Institute for Regenerative Medicine. Kelly is currently a principal scientist at Rochal Industries LLC, in charge of developing medical device and drug products from R&D to manufacturing, regulatory approvals, and clinical trials.
Maggie is a Ph.D. candidate in Biomedical Engineering at the University of Florida. She researches under Dr. Greg Hudalla and her dissertation is focused on engineering proteins that interact with carbohydrates. Maggie’s research includes stabilizing protein structures post-translationally and developing novel, self-assembling protein fusions with hopes of improving immunomodulatory protein therapies.